乙型肝炎疫苗无反应及相关危险因素:来自队列研究的见解

IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Journal of Tropical Medicine Pub Date : 2025-03-27 eCollection Date: 2025-01-01 DOI:10.1155/jotm/3879562
Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa'adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar
{"title":"乙型肝炎疫苗无反应及相关危险因素:来自队列研究的见解","authors":"Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa'adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar","doi":"10.1155/jotm/3879562","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality. Despite the efficacy of the hepatitis B vaccine in inducing immunity, a subset of vaccinated individuals fails to achieve adequate immunity. This study investigated the factors influencing immunological response to the hepatitis B vaccine among Nigerian adults. A cohort study was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto, involving 307 participants aged 19-60 who had not previously received the hepatitis B vaccine. Data were collected using structured questionnaires assessing demographic characteristics, medical history, and lifestyle factors. Participants received GeneVac-B, a recombinant hepatitis B vaccine, and 0-, 1-, and 2-month schedule anti-HB levels were measured post-vaccination using a commercial enzyme-linked immunosorbent assay (ELISA) kit (AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA) to classify vaccine response. The association between demographic and lifestyle factors and vaccine response was analyzed using IBM SPSS Statistics (Version 25). Of the 307 participants, 209 received the first vaccine dose, and 192 completed all three doses. Anti-HB quantification revealed that 94.3% of the participants achieved protective immunity (≥ 10 IU/L), while 5.7% were classified as nonresponders (< 10 IU/L). Statistical analysis indicated significant differences in the immune response based on gender (<i>p</i> = 0.031), with females exhibiting higher mean anti-HB levels than males. Negative correlations were observed between age and vaccine response (<i>ρ</i> = -0.296, <i>p</i> < 0.01) and between body mass index (BMI) and response, although the latter was not statistically significant (<i>ρ</i> = -0.131, <i>p</i> = 0.071). Prior tuberculosis, malaria, measles, smoking, and alcohol use showed no significant impact on the immune response, although recurrent malaria, measles, and smoking were associated with slightly lower mean antibody levels. The study indicates gender and age significantly influence hepatitis B vaccine response, with females and younger individuals demonstrating stronger immunity.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"3879562"},"PeriodicalIF":2.1000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968161/pdf/","citationCount":"0","resultStr":"{\"title\":\"Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study.\",\"authors\":\"Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa'adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar\",\"doi\":\"10.1155/jotm/3879562\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality. Despite the efficacy of the hepatitis B vaccine in inducing immunity, a subset of vaccinated individuals fails to achieve adequate immunity. This study investigated the factors influencing immunological response to the hepatitis B vaccine among Nigerian adults. A cohort study was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto, involving 307 participants aged 19-60 who had not previously received the hepatitis B vaccine. Data were collected using structured questionnaires assessing demographic characteristics, medical history, and lifestyle factors. Participants received GeneVac-B, a recombinant hepatitis B vaccine, and 0-, 1-, and 2-month schedule anti-HB levels were measured post-vaccination using a commercial enzyme-linked immunosorbent assay (ELISA) kit (AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA) to classify vaccine response. The association between demographic and lifestyle factors and vaccine response was analyzed using IBM SPSS Statistics (Version 25). Of the 307 participants, 209 received the first vaccine dose, and 192 completed all three doses. Anti-HB quantification revealed that 94.3% of the participants achieved protective immunity (≥ 10 IU/L), while 5.7% were classified as nonresponders (< 10 IU/L). Statistical analysis indicated significant differences in the immune response based on gender (<i>p</i> = 0.031), with females exhibiting higher mean anti-HB levels than males. Negative correlations were observed between age and vaccine response (<i>ρ</i> = -0.296, <i>p</i> < 0.01) and between body mass index (BMI) and response, although the latter was not statistically significant (<i>ρ</i> = -0.131, <i>p</i> = 0.071). Prior tuberculosis, malaria, measles, smoking, and alcohol use showed no significant impact on the immune response, although recurrent malaria, measles, and smoking were associated with slightly lower mean antibody levels. The study indicates gender and age significantly influence hepatitis B vaccine response, with females and younger individuals demonstrating stronger immunity.</p>\",\"PeriodicalId\":17527,\"journal\":{\"name\":\"Journal of Tropical Medicine\",\"volume\":\"2025 \",\"pages\":\"3879562\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968161/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Tropical Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/jotm/3879562\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tropical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/jotm/3879562","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

乙型肝炎病毒(HBV)感染仍然是一个严重的全球卫生问题,特别是在全球发病率和死亡率很高的高负担地区。尽管乙型肝炎疫苗在诱导免疫方面有效,但一部分接种疫苗的个体未能获得充分的免疫。本研究调查了尼日利亚成年人对乙肝疫苗免疫反应的影响因素。在索科托Usmanu Danfodiyo大学教学医院进行了一项队列研究,涉及307名年龄在19-60岁之间、以前未接种过乙型肝炎疫苗的参与者。数据采用结构化问卷收集,评估人口特征、病史和生活方式因素。参与者接种了重组乙型肝炎疫苗genevacb,接种后使用商用酶联免疫吸附测定(ELISA)试剂盒(AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA)测量0、1和2个月的抗hb水平,以分类疫苗反应。使用IBM SPSS Statistics (Version 25)分析人口统计学和生活方式因素与疫苗应答之间的关系。在307名参与者中,209人接种了第一剂疫苗,192人接种了全部三剂疫苗。抗hb定量显示,94.3%的参与者获得保护性免疫(≥10 IU/L),而5.7%的参与者被归类为无反应(< 10 IU/L)。统计分析表明,免疫反应在性别上存在显著差异(p = 0.031),女性的平均抗hb水平高于男性。年龄与疫苗应答呈负相关(ρ = -0.296, p < 0.01),体质指数(BMI)与应答呈负相关,但后者无统计学意义(ρ = -0.131, p = 0.071)。既往结核病、疟疾、麻疹、吸烟和饮酒对免疫反应没有显著影响,尽管复发性疟疾、麻疹和吸烟与平均抗体水平略低相关。研究表明,性别和年龄显著影响乙肝疫苗应答,女性和年轻人表现出更强的免疫力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study.

Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality. Despite the efficacy of the hepatitis B vaccine in inducing immunity, a subset of vaccinated individuals fails to achieve adequate immunity. This study investigated the factors influencing immunological response to the hepatitis B vaccine among Nigerian adults. A cohort study was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto, involving 307 participants aged 19-60 who had not previously received the hepatitis B vaccine. Data were collected using structured questionnaires assessing demographic characteristics, medical history, and lifestyle factors. Participants received GeneVac-B, a recombinant hepatitis B vaccine, and 0-, 1-, and 2-month schedule anti-HB levels were measured post-vaccination using a commercial enzyme-linked immunosorbent assay (ELISA) kit (AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA) to classify vaccine response. The association between demographic and lifestyle factors and vaccine response was analyzed using IBM SPSS Statistics (Version 25). Of the 307 participants, 209 received the first vaccine dose, and 192 completed all three doses. Anti-HB quantification revealed that 94.3% of the participants achieved protective immunity (≥ 10 IU/L), while 5.7% were classified as nonresponders (< 10 IU/L). Statistical analysis indicated significant differences in the immune response based on gender (p = 0.031), with females exhibiting higher mean anti-HB levels than males. Negative correlations were observed between age and vaccine response (ρ = -0.296, p < 0.01) and between body mass index (BMI) and response, although the latter was not statistically significant (ρ = -0.131, p = 0.071). Prior tuberculosis, malaria, measles, smoking, and alcohol use showed no significant impact on the immune response, although recurrent malaria, measles, and smoking were associated with slightly lower mean antibody levels. The study indicates gender and age significantly influence hepatitis B vaccine response, with females and younger individuals demonstrating stronger immunity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Tropical Medicine
Journal of Tropical Medicine Immunology and Microbiology-Parasitology
CiteScore
3.90
自引率
4.50%
发文量
0
审稿时长
14 weeks
期刊介绍: Journal of Tropical Medicine is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies on all aspects of tropical diseases. Articles on the pathology, diagnosis, and treatment of tropical diseases, parasites and their hosts, epidemiology, and public health issues will be considered. Journal of Tropical Medicine aims to facilitate the communication of advances addressing global health and mortality relating to tropical diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信